87 related articles for article (PubMed ID: 7882347)
1. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma.
Bhatia K; Fan S; Spangler G; Weintraub M; O'Connor PM; Judde JG; Magrath I
Cancer Res; 1995 Apr; 55(7):1431-5. PubMed ID: 7882347
[TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines.
Terry LA; Boyd J; Alcorta D; Lyon T; Solomon G; Hannon G; Berchuck A; Beach D; Barrett JC
Mol Carcinog; 1996 Aug; 16(4):221-8. PubMed ID: 8784465
[TBL] [Abstract][Full Text] [Related]
3. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A
Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer.
Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R
Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685
[TBL] [Abstract][Full Text] [Related]
5. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1.
Chedid M; Michieli P; Lengel C; Huppi K; Givol D
Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608
[TBL] [Abstract][Full Text] [Related]
6. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
7. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
[TBL] [Abstract][Full Text] [Related]
8. [Detection of point mutations in promoter and coding sequence of p21 gene in a variety of human malignancies].
Huang Q; Tao Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):169-72. PubMed ID: 10837517
[TBL] [Abstract][Full Text] [Related]
9. Novel polymorphism in p21(waf1/cip1) cyclin dependent kinase inhibitor gene: association with human esophageal cancer.
Bahl R; Arora S; Nath N; Mathur M; Shukla NK; Ralhan R
Oncogene; 2000 Jan; 19(3):323-8. PubMed ID: 10656678
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Nomdedéu JF; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Haematologica; 1997; 82(5):550-4. PubMed ID: 9407719
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by the p53-273L (Arg --> Leu) mutant in HSC3 cells without transactivation of p21Waf1/Cip1/Sdi1 and bax.
Kaneuchi M; Yamashita T; Shindoh M; Segawa K; Takahashi S; Furuta I; Fujimoto S; Fujinaga K
Mol Carcinog; 1999 Sep; 26(1):44-52. PubMed ID: 10487521
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe L; Orlow I; Silver D; Gerald WL; Fair WR; Reuter VE; Cordon-Cardo C
Oncol Res; 1996; 8(10-11):409-14. PubMed ID: 9114433
[TBL] [Abstract][Full Text] [Related]
13. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
14. Expression and sequence analysis of the p21(WAF1/CIP1) gene in renal cancers.
Papandreou CN; Bogenrieder T; Loganzo F; Albino AP; Nanus DM
Urology; 1997 Mar; 49(3):481-6. PubMed ID: 9123723
[TBL] [Abstract][Full Text] [Related]
15. No point mutation but a codon 31ser-->arg polymorphism of the WAF-1/CIP-1/p21 tumor suppressor gene in nasopharyngeal carcinoma (NPC): the polymorphism distinguishes Caucasians from Chinese.
Sun Y; Hildesheim A; Li H; Li Y; Chen JY; Cheng YJ; Hayes RB; Rothman N; Bi WF; Cao Y
Cancer Epidemiol Biomarkers Prev; 1995; 4(3):261-7. PubMed ID: 7606201
[TBL] [Abstract][Full Text] [Related]
16. Low levels of expression of an inhibitor of cyclin-dependent kinases (CIP1/WAF1) in primary breast carcinomas with p53 mutations.
Ozçelik H; Mousses S; Andrulis IL
Clin Cancer Res; 1995 Aug; 1(8):907-12. PubMed ID: 9816061
[TBL] [Abstract][Full Text] [Related]
17. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
[TBL] [Abstract][Full Text] [Related]
18. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
[TBL] [Abstract][Full Text] [Related]
19. p53 expression overcomes p21WAF1/CIP1-mediated G1 arrest and induces apoptosis in human cancer cells.
Kagawa S; Fujiwara T; Hizuta A; Yasuda T; Zhang WW; Roth JA; Tanaka N
Oncogene; 1997 Oct; 15(16):1903-9. PubMed ID: 9365236
[TBL] [Abstract][Full Text] [Related]
20. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
Shi Y; Zou M; Farid NR; al-Sedairy ST
Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
